C12Y 104/03
Oxidoreductases acting on the ch-nh2 group of donors: with oxygen as acceptor
Official title: with oxygen as acceptor (1.4.3)
C12Y104/03 (Oxidoreductases acting on the ch-nh2 group of donors: with oxygen as acceptor) appears on 155 US grants and 313 published applications in this corpus.
Search patents in C12Y- Granted patents
- 155
- Published applications
- 313
- Assignees
- 136
- Inventors
- 492
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 3 |
| 2003 | 1 | 6 |
| 2004 | 1 | 11 |
| 2005 | 0 | 39 |
| 2006 | 1 | 7 |
| 2007 | 3 | 7 |
| 2008 | 2 | 12 |
| 2009 | 1 | 7 |
| 2010 | 5 | 9 |
| 2011 | 4 | 7 |
| 2012 | 6 | 8 |
| 2013 | 6 | 13 |
| 2014 | 7 | 5 |
| 2015 | 4 | 11 |
| 2016 | 7 | 12 |
| 2017 | 8 | 17 |
| 2018 | 12 | 15 |
| 2019 | 6 | 17 |
| 2020 | 13 | 16 |
| 2021 | 5 | 12 |
| 2022 | 5 | 20 |
| 2023 | 12 | 19 |
| 2024 | 13 | 9 |
| 2025 | 17 | 20 |
| 2026 | 8 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 104/03013Protein-lysine 6-oxidase , i.e. lysyl-oxidase33
- C12Y 104/03003D-amino-acid oxidase30
- C12Y 104/03002L-amino-acid oxidase26
- C12Y 104/03004Monoamine oxidase21
- C12Y 104/03006Amine oxidase18
- C12Y 104/03022Diamine oxidase9
- C12Y 104/03011L-glutamate oxidase8
- C12Y 104/03016L-aspartate oxidase7
All 21 subgroupsShow fewer
- C12Y 104/03019Glycine oxidase3
- C12Y 104/03007D-glutamate oxidase2
- C12Y 104/03014L-lysine oxidase2
- C12Y 104/03021Primary-amine oxidase , i.e. vap-12
- C12Y 104/03005Pyridoxal 5'-phosphate synthase , i.e. pyridoxamine 5-phosphate oxidase1
- C12Y 104/0301Putrescine oxidase1
- C12Y 104/03001D-aspartate oxidase0
- C12Y 104/03008Ethanolamine oxidase0
- C12Y 104/03012Cyclohexylamine oxidase0
- C12Y 104/03015D-glutamate oxidase0
- C12Y 104/0302L-lysine 6-oxidase0
- C12Y 104/030237-chloro-l-tryptophan oxidase0
- C12Y 104/03024Pseudooxynicotine oxidase0
Recent patents
- Enumeration of genetically engineered microorganisms by live cell counting techniques1 Sep 2026US 12,721,882 B2Synlogic Operating Company, Inc.
- Compounds and methods for amine oxidase imaging28 Jul 2026US 12,692,532 B2ETH Zurich
- Heterologous proteins with axonemal proteins7 Jul 2026US 12,673,977 B2The Regents of the University of California
- Persistent memory T-cell responses to cancer and infectious-disease antigens by manipulation of amino acid-catabolism pathways24 Mar 2026US 12,582,709 B2The Regents of the University of California
- Methods for improving yields of L-glufosinate24 Feb 2026US 12,559,777 B2BASF SE
- Tropane Alkaloid (TA) Producing Non-Plant Host Cells, and Methods of Making and Using the Same17 Sep 2026US 2026/0275357 A1The Board of Trustees of the Leland Stanford Junior University
- Method for expressing d-amino acid oxidase and use thereof20 Aug 2026US 2026/0242750 A1Zhejiang Wynca Chemical Industry Group Co., Ltd
- Matrix bound vesicles (mbvs) containing il-33 and their use16 Jul 2026US 2026/0199237 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Fad type glutamate dehydrogenase9 Jul 2026US 2026/0193689 A1Kikkoman Corporation
- Methods for improving yields of l-glufosinate28 May 2026US 2026/0146268 A1BASF SE
Most cited
By later US patents
- Enzymatic powder milk29US 4,617,190 ALaclede Professional Products, Inc. · 1986
- Cyclopropylamines as LSD1 inhibitors25US 9,527,835 B2Incyte Corporation · 2016
- Bacteria engineered to treat a disease or disorder23US 9,889,164 B2Synlogic, Inc. · 2018
- Nucleic acid encoding N-methylputrescine oxidase and uses thereof22US 8,410,341 B2National Research Council of Canada · 2013
- Catalytic domains from lysyl oxidase and LOXL219US 8,927,700 B2Gilead Biologics, Inc. · 2015